Brief: Biogen Provides Update On Private Payer Coverage For Zurzuvae™ (Zuranolone)
05/11/2026 16:19
BRIEF-Biogen Provides Update On Private Payer Coverage For Zurzuvae™ (Zuranolone) Nov 5 (Reuters) - BIOGEN CANADA :
BIOGEN PROVIDES UPDATE ON PRIVATE PAYER COVERAGE FOR ZURZUVAE™ (ZURANOLONE)
BIOGEN CANADA : GROUP BENEFIT HEALTH PLANS NOW REIMBURSE ZURZUVAE™ FOR TREATMENT OF MODERATE OR SEVERE PDP IN ADULTS FOLLOWING CHILDBIRTH
Source text: ID:nBw28N84Ra
Further company coverage: BIIB.O
((((Reuters.Briefs@thomsonreuters.com));))
Recent news on Biogen
See all newsUS RESEARCH ROUNDUP-Autodesk, Metlife, Rollins
Brief: Biogen Says DZP Plus Soc Meets Primary Endpoint Of BICLA Response At Week 48
Brief: Biogen Provides Update On Private Payer Coverage For Zurzuvae™ (Zuranolone)
US RESEARCH ROUNDUP-Eli Lilly, General Dynamics, S&P Global
US RESEARCH ROUNDUP-Baker Hughes, Brinker International, GE Vernova